This page: Cancer rates worldwide
Here are the latest available (2024) statistics, with a link to an interesting article about Cancer Survival rates around the World: Extract: “For the two papers, published in The Lancet Oncology and part-funded by Cancer Research UK, an international team of researchers examined data from over 780,000 people with cancer diagnosed between 2012 and 2017 in four comparable countries (Australia, Canada, Norway and the UK). Eight cancer types were included: oesophageal, stomach, colon, rectal, liver, pancreatic, lung and ovarian cancer.” Read more here
Nation |
Stomach |
Lung |
Breast |
Prostate |
|
|---|---|---|---|---|---|
South Korea |
68.9% |
25.1% |
86.6% |
89.9% |
|
Japan |
60.3% |
32.9% |
89.4% |
93% |
|
Jordan |
55.7% |
28.3% |
84.4% |
86.1% |
|
Algeria |
41.6% |
33.7% |
77% |
64.1% |
|
Costa Rica |
40.6% |
20.1% |
86.7% |
93.2% |
|
Gibraltar |
39.2% |
19.6% |
72.1% |
42.3% |
|
Taiwan |
38.6% |
20.6% |
84.2% |
83% |
|
Belgium |
37.5% |
18.2% |
86.4% |
93.8% |
|
China |
35.9% |
19.8% |
83.2% |
69.2% |
|
Cuba |
35.7% |
30.1% |
75.1% |
71.4% |
|
Cyprus |
35.6% |
18.7% |
92.8% |
99.2% |
|
Austria |
35.4% |
19.7% |
84.8% |
90.2% |
|
Puerto Rico |
34.6% |
17.6% |
84.1% |
98.4% |
|
Germany |
33.5% |
18.3% |
86% |
91.6% |
|
United States |
33.1% |
21.2% |
90.2% |
97.4% |
|
Israel |
32.3% |
26.6% |
88% |
95.6% |
|
Portugal |
32.2% |
15.7% |
87.6% |
90.9% |
|
Switzerland |
32.2% |
20.4% |
86.2% |
89.2% |
|
Martinique |
32.1% |
11.8% |
89.8% |
97.9% |
|
Australia |
31.8% |
19.4% |
89.5% |
94.5% |
|
Italy |
30.5% |
15.9% |
86% |
89.5% |
|
Singapore |
30.3% |
15.5% |
80.3% |
87.8% |
|
Malaysia |
30% |
10.1% |
65% |
87.7% |
|
Canada |
29.6% |
20.6% |
88.2% |
93.6% |
|
Estonia |
29.2% |
16.9% |
76.6% |
86.3% |
|
Slovenia |
28.8% |
14.8% |
83.5% |
85% |
|
Latvia |
28% |
20.4% |
72.1% |
90.4% |
|
Spain |
27.6% |
13.5% |
85.2% |
89.7% |
|
Ireland |
27.6% |
17.5% |
82% |
91.1% |
|
Iceland |
27.6% |
20.2% |
89.1% |
90.8% |
|
Lithuania |
27% |
9.9% |
73.5% |
94.3% |
|
France |
26.7% |
17.3% |
86.7% |
93.1% |
|
Norway |
26.5% |
19% |
87.7% |
92.9% |
|
Russia |
26% |
13.7% |
70.8% |
79.3% |
|
Romania |
26% |
11.1% |
74.8% |
77.1% |
|
Finland |
25.7% |
13% |
88.5% |
93.2% |
|
New Zealand |
25.7% |
15.3% |
87.6% |
90.3% |
|
Mauritius |
25.7% |
20.4% |
83.6% |
63.5% |
|
South Africa |
25.6% |
15% |
40.1% |
37.8% |
|
Netherlands |
25% |
17.3% |
86.6% |
88.5% |
|
Sweden |
24.8% |
19.5% |
88.8% |
90.7% |
|
Turkey |
24.6% |
14.9% |
82.1% |
83.8% |
|
Malta |
23.8% |
14.9% |
86.9% |
88.2% |
|
Kuwait |
22.4% |
25.1% |
75.2% |
84.0% |
|
Argentina |
21.5% |
13.1% |
84.4% |
87.6% |
|
Slovakia |
21.1% |
11.2% |
75.5% |
74.7% |
|
Poland |
20.9% |
14.4% |
76.5% |
78.1% |
|
United Kingdom |
20.7% |
13.3% |
85.6% |
88.7% |
|
Brazil |
20.6% |
8.5% |
75.2% |
91.6% |
|
Czechia |
20.6% |
10.6% |
81.4% |
85.3% |
|
Croatia |
20% |
10% |
78.6% |
80.9% |
|
Denmark |
19.9% |
16.6% |
86.1% |
85.6% |
|
Ecuador |
19.1% |
12.2% |
75.5% |
82.2% |
|
Uruguay |
18.5% |
9% |
86.5% |
||
Qatar |
17.5% |
17.2% |
71.9% |
89.6% |
|
Colombia |
17.1% |
8.7% |
72.1% |
80.3% |
|
Chile |
16.7% |
4.6% |
75.5% |
82% |
|
Thailand |
12.5% |
8.6% |
68.7% |
68% |
|
Guadeloupe |
11.7% |
4% |
50.2% |
71.4% |
|
India |
8.9% |
3.7% |
66.1% |
44.3% |
|
Iran |
5.7% |
n/a |
n/a |
n/a |
|
Nigeria |
n/a |
n/a |
97.5% |
58.7% |
|
Morocco |
n/a |
n/a |
99.7% |
n/a |
|
Peru |
n/a |
n/a |
84% |
n/a |
|
Hong Kong |
n/a |
n/a |
83.3% |
n/a |
|
Bulgaria |
n/a |
7.7% |
78.3% |
68.3% |
Sources: The National Cancer Institute, Cancer Research UK | World Population Review